Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: acyclovir

« Back to Dashboard

Summary for Generic Name: acyclovir

Tradenames:6
Patents:6
Applicants:33
NDAs:59
Drug Master File Entries: see list52
Suppliers: see list9
Therapeutic Class:Antivirals

Clinical Trials for: acyclovir

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Status: Completed Condition: Genital Herpes; HIV Infection

Effect of Body Mass on Acyclovir Pharmacokinetics
Status: Active, not recruiting Condition: Hematological Malignancy; Pharmacokinetics of Acyclovir

HSV-2 Shedding Resolution After Acyclovir Treatment
Status: Completed Condition: Genital Herpes

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
Status: Completed Condition: HIV Infections; Herpes Genitalis

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
Status: Completed Condition: Genital Herpes

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
Status: Active, not recruiting Condition: Genital Herpes

Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Status: Completed Condition: Herpes Simplex

Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Status: Completed Condition: Herpes Simplex

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
Status: Completed Condition: HIV Infections; Herpesvirus 2, Human

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Status: Completed Condition: HSV Infection; HIV Infection

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603Oct 22, 1982DISCNNo<disabled><disabled>
Dava Pharms Inc
ACYCLOVIR
acyclovir
TABLET;ORAL074946Nov 19, 1997RXNo<disabled><disabled>
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603Jun 29, 1989DISCNNo<disabled><disabled>
Cadila Pharms Ltd
ACYCLOVIR
acyclovir
CAPSULE;ORAL201445Mar 6, 2014RXNo<disabled><disabled>
Ranbaxy
ACYCLOVIR
acyclovir
CAPSULE;ORAL074975Sep 30, 1998RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc